Cogent Biosciences (COGT) Convertible Debt (2021 - 2026)
Cogent Biosciences (COGT) posted Convertible Debt of $223.46 million for Q2 2026, up 0.1% from the prior quarter.
Powered by 
Analysis
Cogent Biosciences (COGT) Convertible Debt (2021 - 2026) Analysis & Trends
At the end of FY2025, Cogent Biosciences' Convertible Debt came in at $222.9 million.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Cogent Biosciences | 5.50 Bn | 2.15 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 223.74 Mn |
| Jun 30, 2026 | 223.46 Mn |
| Mar 31, 2026 | 223.17 Mn |
| Dec 31, 2025 | 222.90 Mn |
| Mar 31, 2021 | -343,000.00 |
API Access
Cogent Biosciences Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=COGT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "COGT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=COGT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();